The Well News on MSN
FDA Draft Guidance Places New Limits on Toxicity Tests Involving Primates
WASHINGTON - The Food and Drug Administration released a draft guidance on Tuesday significantly reducing the range of ...
The Physicians Committee for Responsible Medicine applauds the Food and Drug Administration’s newly released draft guidance, ...
The agency is proposing drugmakers use shorter nonrodent studies and other sources of evidence when developing monoclonal antibodies for non-cancer settings.
Clinical Trials Arena on MSN
FDA steps back from preclinical primate testing amid wider regulatory shift
New non-primate draft guidance follows the agency’s wider aim to curtail the use of animal testing in preclinical toxicology.
The draft guidance issued Tuesday comes as regulators and policymakers have looked for ways to aid U.S. drugmakers amid fast progress by their China-based counterparts.
On , The US Food and Drug Administration issued draft guidance identifying specific types of monoclonal antibody products for which the agency believes six-month toxicity testing in non-human primates ...
FDA moves reshaping drug policy include fast-track programs, updated biosimilar guidance, and new rare disease approval pathways.
The FDA encourages sponsors to discuss plans to use animal testing alternatives, called new approach methodologies or NAMs, ...
The U.S. Food and Drug Administration on Tuesday issued new draft guidance on reducing the use of lab monkeys in preclinical ...
New guidelines from the World Health Organization (WHO) recommend using GLP-1 medications to help manage obesity along with a ...
The FDA plans to impose stricter vaccine approval rules, prompting warnings from Georgia doctors who fear the policy could ...
The FDA is offering staff a broad set of agentic AI tools despite concerns that the technology can behave unpredictably ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback